For years, hormone replacement therapy (HRT) for women carried a black label that shaped fear, hesitation, and misinformation — despite many women experiencing real relief and improved quality of life. Now, the FDA has gone back to review the research, and the narrative is finally shifting.In this episode, we break down the old studies that originally led to caution around HRT, why those conclusions were flawed or misunderstood, and the new evidence that supports its benefits for many women — especially during menopause. We’ll also talk about what it means that the FDA is now backing something women’s health professionals have known for decades.This conversation isn’t just about hormones — it’s about progress. Women’s health is finally being brought to the forefront instead of pushed to the back burner, and menopause is being treated as a real, impactful phase of life that deserves proper care, research, and support.If you’re curious about HRT, menopause, or the future of women’s health, this episode is for you.